Domov › Crohnova bolezen › Missouri › St. Louis
Klinične študije za Crohnova bolezen v St. Louis, MO
19 študij za Crohnova bolezen išče udeležence na lokacijah v St. Louis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Vključevanje udeležencevFaza 2
- Specialists In Gastroenterology /ID# 283939, St Louis
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Vključevanje udeležencevFaza 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- in še 1
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Vključevanje udeležencevFaza 3
- Washington University School of Medicine ( Site 5058), St Louis
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Vključevanje udeležencevFaza 4
- SSM Health Medical Group, Bridgeton · 15 mi stran
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Vključevanje udeležencevFaza 2
- Washington University /ID# 266938, St Louis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Vključevanje udeležencevFaza 3
- Washington University School of Medicine, St Louis
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Vključevanje udeležencevFaza 3
- Washington University School of Medicine-Site Number: 8400075, St Louis
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Vključevanje udeležencevFaza 3
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Vključevanje udeležencevFaza 3
- Washington University School of Medicine, St Louis
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Vključevanje udeležencevFaza 2
- KAD Clinical Research, St Louis
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Vključevanje udeležencevFaza 2
- SSM Health DePaul Hospital- St. Louis, Bridgeton · 15 mi stran
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Vključevanje udeležencevFaza 2
- KAD Clinical Research, St Louis
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Vključevanje udeležencevFaza 4
- Washington University School of Medicine, St Louis
DB-3Q for the Treatment of Medically Refractory Crohn's Disease
Vključevanje udeležencevFaza 2
- Washington University, St. Louis, St Louis
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
Vključevanje udeležencevFaza 2
- Washington University School of Medicine, St Louis
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Vključevanje udeležencevFaza 2
- Investigational Site Number: 8400013, St Louis
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Vključevanje udeležencevFaza 2
- Mirador Therapeutics Selected Site, Bridgeton · 15 mi stran
Treatment of Moderate to Severe Refractory Crohn's Disease
Vključevanje udeležencevFaza 1/2
- Washington University in St. Louis, St Louis
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
Vključevanje udeležencevOpazovalna študija
- Washington University in St Louis School of Medicine, St Louis
Študije za Crohnova bolezen v drugih mestih
- New York City, NY35 študij
- Boston, MA19 študij
- Miami, FL19 študij
- Cleveland, OH19 študij
- Tyler, TX17 študij
- Houston, TX17 študij
- Orlando, FL17 študij
- Atlanta, GA17 študij
- San Antonio, TX15 študij
- San Diego, CA15 študij
- Los Angeles, CA15 študij
- Colorado Springs, CO13 študij
Druge študije v St. Louis
- Nemalicelični pljučni rak73 študij
- Rak dojke64 študij
- Metastatski rak54 študij
- Kolorektalni rak50 študij
- Rak (vse vrste)46 študij
- Rak prostate46 študij
- Rak pljuč39 študij
- Rak jajčnikov38 študij
- Rak trebušne slinavke33 študij
- Rak endometrija29 študij
- Ploščatocelični karcinom glave in vratu28 študij
- Srčno popuščanje26 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.